| 1 | 2-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE | - | - | - | - | [2] 6 6, 162 💬
|
| 2 | [clobetasolo propionato] | - | - | - | - | [1] 162 162 💬
|
| 3 | [MEDI-563] | - | - | - | - | [5] 44 44, 45, 98, 162, 299 💬
|
| 4 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 5 | Abrocitinib | [1] Abrocitinib Abrocitinib | [1] Abrocitinib
Abrocitinib
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [3] 39 39, 84, 162 💬
|
| 6 | AC-203 1% Topical Ointment | - | - | - | - | [1] 162 162 💬
|
| 7 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 8 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
| 9 | Adalimumab Injection | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5] 38 38, 40, 46, 96, 162 💬
|
| 10 | AKST4290 | - | - | - | - | [2] 6 6, 162 💬
|
| 11 | ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED | - | - | - | - | [5] 36 36, 38, 53, 96, 162 💬
|
| 12 | Allogenic mesenchymal stem cell isolated from adipose tissue | - | - | - | - | [3] 38 38, 96, 162 💬
|
| 13 | Apremilast | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [8] 36 36, 46, 50, 56, 97, 107, 162, 271 💬
|
| 14 | ARAVA | - | - | - | - | [4] 46 46, 53, 54, 162 💬
|
| 15 | Avdoralimab | [1] Avdoralimab Avdoralimab | - | - | - | [1] 162 162 💬
|
| 16 | Avdoralimab (IPH5401) | [1] Avdoralimab Avdoralimab | - | - | - | [1] 162 162 💬
|
| 17 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 18 | Azathioprine or Mycophenolate mofetil | [2] Azathioprine Azathioprine, Mycophenolate mofetil | [4] Azathioprine
Azathioprine
,
Mycophenolate mofetil
,
Azathioprine sodium
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 162 162 💬
|
| 19 | Baricitinib | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [24] 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 20 | Baricitinib 2 MG [Olumiant] | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 63 63, 162 💬
|
| 21 | Benralizumab | [1] Benralizumab Benralizumab | [1] Benralizumab
Benralizumab
💬
| [1] IL5RA IL5RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [5] 44 44, 45, 98, 162, 299 💬
|
| 22 | Bertilimumab | [1] Bertilimumab Bertilimumab | - | - | - | [2] 97 97, 162 💬
|
| 23 | BIV009 | - | - | - | - | [2] 61 61, 162 💬
|
| 24 | Blood sampling | - | - | - | - | [15] 2 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
|
| 25 | Blood test | - | - | - | - | [19] 2 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
|
| 26 | Bone densitometry | - | - | - | - | [2] 49 49, 162 💬
|
| 27 | Carboxymethylcellulose | [1] Carboxymethylcellulose Carboxymethylcellulose | [2] Carboxymethylcellulose sodium
Carboxymethylcellulose sodium
,
Carmellose
💬
| - | - | [3] 35 35, 70, 162 💬
|
| 28 | Carboxymethylcellulose with ionic silver (Aquacel Ag) | [2] Carboxymethylcellulose Carboxymethylcellulose, Silver | [2] Carboxymethylcellulose sodium
Carboxymethylcellulose sodium
,
Carmellose
💬
| - | - | [2] 35 35, 162 💬
|
| 29 | CC-10004 | - | - | - | - | [5] 46 46, 56, 97, 162, 271 💬
|
| 30 | Cellcept® in autoimmune bullous dermatoses | - | - | - | - | [2] 35 35, 162 💬
|
| 31 | Cellulose acetate with petrolatum | [2] Acetate Acetate, Petrolatum | [2] Petrolatum, white
Petrolatum, white
,
Petrolatum
💬
| - | - | [2] 35 35, 162 💬
|
| 32 | Clobetasol | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [5] 35 35, 39, 46, 51, 162 💬
|
| 33 | Clobetasol 0.05% Topical Ointment | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 34 | Clobetasol propionate | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 35 35, 46, 162 💬
|
| 35 | Clobetasol propionate + Methotrexate | [3] Clobetasol Clobetasol, Clobetasol propionate, Methotrexate | [4] Methotrexate
Methotrexate
,
Clobetasol propionate
,
Methotrexate sodium
,
Clobetasol
💬
| [3] DHFR DHFR, DHFR2, NR3C1 💬
| [4] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | [1] 162 162 💬
|
| 36 | Clobetasol propionate alone | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 37 | Clobetasol Propionate cream treatment | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 38 | Clobetasolo propionato | - | - | - | - | [1] 162 162 💬
|
| 39 | Collagenase | - | - | - | - | [1] 162 162 💬
|
| 40 | CORTANCYL 20 mg | - | - | - | - | [2] 35 35, 162 💬
|
| 41 | Cotton | [1] Cotton Cotton | - | - | - | [2] 35 35, 162 💬
|
| 42 | Cotton gauze with petrolatum | [2] Cotton Cotton, Petrolatum | [2] Petrolatum, white
Petrolatum, white
,
Petrolatum
💬
| - | - | [2] 35 35, 162 💬
|
| 43 | Cultivated oral mucosal epithelial sheet transplantation | - | - | - | - | [2] 38 38, 162 💬
|
| 44 | Cutaneous biopsy | - | - | - | - | [1] 162 162 💬
|
| 45 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 46 | Cyclophosphamide 50Mg Oral Tablet | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 162 162 💬
|
| 47 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 48 | DACORTIN | - | - | - | - | [2] 97 97, 162 💬
|
| 49 | Dapsone | [1] Dapsone Dapsone | [1] Dapsone
Dapsone
💬
| - | - | [6] 35 35, 42, 60, 63, 84, 162 💬
|
| 50 | Data report | - | - | - | - | [1] 162 162 💬
|
| 51 | Dermoval | - | - | - | - | [2] 35 35, 162 💬
|
| 52 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 53 | Dexamethasone 0.5mg/5ml solution | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 💬
|
| 54 | Dexamethasone 0.5mg/5ml solution in Mucolox™ | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 💬
|
| 55 | DF2156A | - | - | - | - | [1] 162 162 💬
|
| 56 | Diagnostic Test: clobetasol decreasing measurement | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 57 | Double Dose | - | - | - | - | [2] 38 38, 162 💬
|
| 58 | Doxycycline | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [17] 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
|
| 59 | Dupilumab | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [8] 51 51, 97, 98, 160, 162, 222, 300, 306 💬
|
| 60 | Dupixent | - | - | - | - | [3] 98 98, 160, 162 💬
|
| 61 | EFGARTIGIMOD ALFA | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [7] 11 11, 13, 14, 35, 53, 63, 162 💬
|
| 62 | Efgartigimod PH20 SC | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [7] 11 11, 14, 35, 50, 53, 63, 162 💬
|
| 63 | ENDOXAN | - | - | - | - | [6] 13 13, 28, 49, 51, 85, 162 💬
|
| 64 | Fasenra | - | - | - | - | [5] 44 44, 45, 98, 162, 299 💬
|
| 65 | Galen | - | - | - | - | [1] 162 162 💬
|
| 66 | Genetic: A single blood sample for HLA typing | - | - | - | - | [3] 35 35, 38, 162 💬
|
| 67 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 68 | Halometasone | [1] Halometasone Halometasone | [1] Halometasone
Halometasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 69 | Imatinib | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [12] 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
|
| 70 | Impedance analysis | - | - | - | - | [1] 162 162 💬
|
| 71 | Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
|
| 72 | IPH5401 | - | - | - | - | [1] 162 162 💬
|
| 73 | Ixekizumab | [1] Ixekizumab Ixekizumab | [1] Ixekizumab
Ixekizumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [8] 36 36, 37, 46, 107, 160, 162, 269, 271 💬
|
| 74 | Janus Kinase Inhibitor | - | - | - | - | [4] 46 46, 97, 110, 162 💬
|
| 75 | Ladarixin | [1] Ladarixin Ladarixin | - | - | - | [1] 162 162 💬
|
| 76 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | [4] Dapsone Dapsone, Mycophenolate mofetil, Prednisolone, Triamcinolone | [8] Triamcinolone
Triamcinolone
,
Prednisolone
,
Dapsone
,
Mycophenolate mofetil
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 162 162 💬
|
| 77 | Leflunomide | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [14] 11 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
|
| 78 | Liquid bubble sampling | - | - | - | - | [1] 162 162 💬
|
| 79 | Mabthera | - | - | - | - | [20] 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
|
| 80 | Mabthéra | - | - | - | - | [3] 35 35, 63, 162 💬
|
| 81 | Mathéra | - | - | - | - | [2] 35 35, 162 💬
|
| 82 | MEDI-563 | - | - | - | - | [5] 44 44, 45, 98, 162, 299 💬
|
| 83 | MEPOLIZUMAB | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [4] 44 44, 45, 98, 162 💬
|
| 84 | Mepolizumab (a-IL-5 antibody) | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [1] 162 162 💬
|
| 85 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 86 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 87 | Minocycline | [1] Minocycline Minocycline | [2] Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | [14] 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
| 88 | Mitomycin | [1] Mitomycin Mitomycin | [1] Mitomycin
Mitomycin
💬
| - | - | [3] 94 94, 162, 329 💬
|
| 89 | Mometasone | [1] Mometasone Mometasone | [1] Mometasone
Mometasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 98 98, 162 💬
|
| 90 | MOMETASONE FUROATE | [2] Mometasone Mometasone, Mometasone furoate | [3] Mometasone furoate
Mometasone furoate
,
Mometasone furoate hydrate
,
Mometasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 98 98, 162 💬
|
| 91 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [4] 43 43, 84, 162, 228 💬
|
| 92 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 93 | Myfortic 180 mg | - | - | - | - | [1] 162 162 💬
|
| 94 | Myfortic 180 mg Filmtabletten | - | - | - | - | [1] 162 162 💬
|
| 95 | Nanocrystalline silver (Acticoat) | [1] Silver Silver | - | - | - | [2] 35 35, 162 💬
|
| 96 | Nicotinamide | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [19] 2 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
|
| 97 | NNC0215-0384 | - | - | - | - | [2] 46 46, 162 💬
|
| 98 | NOMACOPAN | [1] Nomacopan Nomacopan | [1] Nomacopan
Nomacopan
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 162 162 💬
|
| 99 | Nomacopan (rVA576) | [1] Nomacopan Nomacopan | [1] Nomacopan
Nomacopan
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 162 162 💬
|
| 100 | NPB-01 | - | - | - | - | [3] 13 13, 14, 162 💬
|
| 101 | Olive oil | [1] Olive oil Olive oil | [1] Olive oil
Olive oil
💬
| - | - | [10] 13 13, 34, 35, 46, 49, 53, 97, 124, 162, 271 💬
|
| 102 | OMALIZUMAB | [1] Omalizumab Omalizumab | [1] Omalizumab
Omalizumab
💬
| [1] FCER1A FCER1A 💬
| [4] Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [7] 46 46, 53, 65, 98, 162, 226, 299 💬
|
| 103 | Oral corticosteroids (OCS) | - | - | - | - | [1] 162 162 💬
|
| 104 | Otezla | - | - | - | - | [3] 56 56, 107, 162 💬
|
| 105 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 106 | Other: Blood sample and cotton skin swabs | [1] Cotton Cotton | - | - | - | [1] 162 162 💬
|
| 107 | Other: Blood sample for dosages of cytokines (IL-17 and IL-23) and of the protease MMP-9 | - | - | - | - | [1] 162 162 💬
|
| 108 | Other: Control | - | - | - | - | [12] 6 6, 19, 67, 70, 75, 85, 96, 97, 162, 193, 226, 296 💬
|
| 109 | Ozonated olive oil | [1] Olive oil Olive oil | [1] Olive oil
Olive oil
💬
| - | - | [2] 35 35, 162 💬
|
| 110 | Petrolatum | [1] Petrolatum Petrolatum | [2] Petrolatum, white
Petrolatum, white
,
Petrolatum
💬
| - | - | [3] 35 35, 158, 162 💬
|
| 111 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 112 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 113 | Prednisone acetate | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] Prednisone
Prednisone
,
Prednisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 35 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
|
| 114 | QGE031 | - | - | - | - | [1] 162 162 💬
|
| 115 | Radiographs of the thoracic and lumbar spine | - | - | - | - | [1] 162 162 💬
|
| 116 | RAY121 | - | - | - | - | [4] 48 48, 50, 63, 162 💬
|
| 117 | Restasis | - | - | - | - | [2] 53 53, 162 💬
|
| 118 | Riboflavin | [1] Riboflavin Riboflavin | [1] Riboflavin
Riboflavin
💬
| - | - | [8] 13 13, 38, 46, 96, 97, 162, 168, 265 💬
|
| 119 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 120 | Rituximab (MABTHERA and BIOSIMILARS) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 35 35, 162 💬
|
| 121 | Rituximab 1g IV | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 162 162 💬
|
| 122 | Rituximab combined with Omalizumab | [2] Omalizumab Omalizumab, Rituximab | [2] Rituximab
Rituximab
,
Omalizumab
💬
| [2] FCER1A FCER1A, MS4A1 💬
| [5] Asthma Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [1] 162 162 💬
|
| 123 | RVA576 | - | - | - | - | [3] 62 62, 109, 162 💬
|
| 124 | Silver | [1] Silver Silver | - | - | - | [2] 35 35, 162 💬
|
| 125 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [22] 6 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
|
| 126 | Simvastatin-ratiopharm | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 162 162 💬
|
| 127 | Simvastatin-ratiopharm® | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 162 162 💬
|
| 128 | Single Dose | - | - | - | - | [2] 38 38, 162 💬
|
| 129 | Solu-Medrone | - | - | - | - | [3] 51 51, 83, 162 💬
|
| 130 | Stapokibart | [1] Stapokibart Stapokibart | - | - | - | [1] 162 162 💬
|
| 131 | Stapokibart injection | [1] Stapokibart Stapokibart | - | - | - | [1] 162 162 💬
|
| 132 | Telitacicept | [1] Telitacicept Telitacicept | - | - | - | [14] 11 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
|
| 133 | Tildrakizumab | [1] Tildrakizumab Tildrakizumab | [1] Tildrakizumab
Tildrakizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 162 162, 271 💬
|
| 134 | Tildrakizumab Prefilled Syringe | [1] Tildrakizumab Tildrakizumab | [1] Tildrakizumab
Tildrakizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 162 162 💬
|
| 135 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 136 | Topical garamycin cream | - | - | - | - | [2] 35 35, 162 💬
|
| 137 | Topical infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 38 38, 39, 162 💬
|
| 138 | Treatment systemic therapy (prednisone) | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 139 | Treatment with systemic therapy (doxycycline) | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 162 162 💬
|
| 140 | Treatment with systemic therapy (methotrexate) | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 162 162 💬
|
| 141 | Treatment with systemic therapy (prednisone) | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 142 | Treatment with topical superpotent corticosteroid therapy | - | - | - | - | [1] 162 162 💬
|
| 143 | Triamcinolone | [1] Triamcinolone Triamcinolone | [4] Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [11] 35 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 💬
|
| 144 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|